Clinical Trials Logo

House Dust Mite Allergy clinical trials

View clinical trials related to House Dust Mite Allergy.

Filter by:

NCT ID: NCT02238353 Recruiting - Allergic Rhinitis Clinical Trials

AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)

Start date: October 2014
Phase: Phase 4
Study type: Interventional

Comparative analysis of the efficacy of intranasal MP29-02 (a novel formulation of azelastine and FP) has already been conducted in patients with moderate-to-severe seasonal AR. The combination formulation appeared to be superior in these patients with better symptomatic relief. However, objective analysis of the effect of this treatment on nasal mediators and/or nasal hyperreactivity has not yet been performed and would help in understanding the additional benefit of the combination treatment over monotherapy with nasal corticosteroids.

NCT ID: NCT01930461 Completed - Asthma Clinical Trials

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Start date: September 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of different doses of sublingual tablets of house dust mite allergen extracts as compared to placebo in adults with house dust mite-associated allergic asthma.

NCT ID: NCT01923792 Completed - Rhinoconjunctivitis Clinical Trials

ToleroMune House Dust Mite Follow on Study

Start date: September 2013
Phase: N/A
Study type: Observational

House Dust Mites (HDM) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDM allergens in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients. ToleroMune HDM is currently being developed for the treatment of HDM allergy. The Purpose of this optional observational follow-on study is to evaluate the continued efficacy of TM-HDM in HDM allergic subjects based on change in TRSS from TH002 baseline approximately two years after the completion of the baseline EEC visit in TH002 following challenge with HDM allergen in an EEC.

NCT ID: NCT01777464 Terminated - Clinical trials for House Dust Mite Allergy

Role of the Central Nervous System in Allergic Rhinitis

Start date: November 2012
Phase: N/A
Study type: Interventional

In order to evaluate the effects a nasal provocation on the activation of different brain regions, the investigators want to set up a clinical trial investigating the short-term effects of a nasal histamine provocation in healthy volunteers and allergic patients while in supine position under the functional MRI device in order to visualize different brain regions.

NCT ID: NCT01608243 Completed - Asthma Clinical Trials

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Start date: May 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety of different doses of sublingual tablets of house dust mite allergen extracts in adults with house dust mite-associated allergic asthma.

NCT ID: NCT01454544 Completed - Clinical trials for House Dust Mite Allergy

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet

MT-06
Start date: October 2011
Phase: Phase 3
Study type: Interventional

The primary aim of this trial is to evaluate the efficacy of the ALK house dust mite tablet given once daily compared to a placebo tablet in the treatment of house dut mite allergic rhinits. Additionally the secondary objective of the trial is to evaluate the safety and tolarability of the ALK house dust mite tablet. Immunotherapy has been shown to provide therapeutic benefits to subjects with house dust mite induced allergy. This trial is planned to investigate if clinically relevant improvements in rhinitis symptoms and with less use of symptomatic medication can be obtained in subjects with a history of poor didease control despite of use of symptomatic medications.

NCT ID: NCT01134757 Completed - Clinical trials for House Dust Mite Allergy

Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.

Start date: January 2011
Phase: N/A
Study type: Interventional

The present study is aimed to evaluate a bronchial allergen challenge with house dust mite and alternaria. Firstly, the years 2005, 2006, 2007, 2008 and 2009 will be retrospectively reviewed. Secondly, in 2010-2013, in the prospective part of the study the patients will undergo the bronchial allergen challenge to examine safety of the bronchial allergen challenge and change of allergen specific bronchial hyperreactivity before and after allergen specific immunotherapy.

NCT ID: NCT00574704 Completed - Clinical trials for House Dust Mite Allergy

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a double-blind, placebo-controlled setting

NCT ID: NCT00574223 Completed - Clinical trials for House Dust Mite Allergy

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Start date: November 2007
Phase: Phase 2
Study type: Interventional

The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a double-blind placebo-controlled setting

NCT ID: NCT00380926 Completed - Allergic Asthma Clinical Trials

Fish Oil and Asthma in House Dust Mite Allergy

Start date: April 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Native populations consuming high amounts of fish suffer less from allergic diseases. The purpose of this study is to determine whether polyunsaturated fatty acids (fish oil) might have a disease modifying influence on asthmatics sensitized to house dust mite.